How Medtech Trends 2026 Are Reshaping North American Manufacturing and Trade

Executive Summary

The medical technology industry is undergoing structural transformation as pricing pressures, shifting care delivery, global trade tensions, and enabling technologies converge. These dynamics are not confined to device manufacturers; they are reshaping regional manufacturing strategies, supply chain configuration, and investment patterns across North America. As companies respond to tariff exposure and geopolitical risk, the USMCA framework provides new opportunities for cross-border integration and nearshoring. This article examines five key medtech trends through the lens of North American trade and industrial competitiveness.

Introduction

Medical technology is a significant component of North American manufacturing, with deep supply chains spanning the United States, Canada, and Mexico. The region's competitiveness depends on its ability to adapt to global trends that affect production costs, market access, and technological leadership. The trends identified in Clarivate's "Medtech Trends to Watch 2026" offer a valuable lens to assess how the sector is evolving and what it means for regional trade and investment.

Main Analysis

1. China's VBP Expansion: A Global Pricing Reset with Regional Implications

Mainland China's volume-based procurement (VBP) program has evolved into a market-structuring mechanism that exerts downward pricing pressure on medical devices worldwide. For North American manufacturers, this means recalibrating portfolio strategies and potentially shifting investment toward higher-value products and markets outside China. The pricing expectations set by VBP can spill over into other emerging markets, influencing global price benchmarks. As a result, North American medtech firms may accelerate innovation in advanced categories, contributing to regional competitiveness.

2. Outpatient Migration: Growth Opportunities and Product Redesign

The shift of procedures to outpatient settings, particularly ambulatory surgical centers (ASCs), is altering demand patterns for medical devices. The U.S. CMS 2026 OPPS/ASC Final Rule expands the ASC Covered Procedure List, allowing higher-acuity procedures to move to lower-cost sites. This trend creates opportunities for North American manufacturers to develop products tailored to these settings, potentially increasing exports of such devices. Additionally, it impacts supply chain logistics, as demand becomes more distributed across care sites.

3. Supply Chain Pressures: The Case for Regionalized Manufacturing

Tariff exposure and geopolitical uncertainty are prompting medtech companies to diversify sourcing and pursue multi-region manufacturing footprints. North America, with its established industrial base and the USMCA trade agreement, is emerging as an attractive destination for nearshoring. Mexico, in particular, benefits from its proximity and trade preferences, seeing increased foreign direct investment in medical device manufacturing. The United States and Canada also play roles in high-value components and innovation. This regionalization enhances supply chain resilience but requires ongoing investments in logistics and infrastructure.

4. GLP-1 Therapies: Ripple Effects Across Medical Device Markets

The rapid adoption of GLP-1 receptor agonists for weight management is reshaping clinical pathways, with potential impacts on procedures such as bariatric surgery and related device demand. North American medtech companies must anticipate these shifts and adjust their product pipelines. The downstream effects on monitoring devices, cardiovascular care, and sleep apnea represent areas for both opportunities and risks. Trade flows may be affected as demand for certain devices changes, and companies may redirect manufacturing capacity accordingly.

5. Enabling Technologies: Platform-Based Competition and Digital Manufacturing

Robotics, imaging, navigation, and digital workflow software are moving from accessories to core components of medtech ecosystems. North American firms, supported by a strong technology sector and AI capabilities, are well-positioned to lead this platform-based competition. The integration of AI and digital manufacturing into medical device production enhances efficiency and could strengthen the region's competitiveness. It also aligns with broader industrial policy objectives around advanced manufacturing and digital economy.

Trade Impact

The medtech trends have profound trade implications. Regionalization of manufacturing under the USMCA could increase intra-regional trade in medical devices and components. As companies shift production to Mexico to serve both North American and global markets, cross-border logistics and border infrastructure become critical. Tariff policies and trade agreements will directly influence investment decisions. Moreover, the demand for critical materials and advanced components can affect trade flows with non-regional partners, potentially increasing North American imports of specialized inputs.

Regional Perspective

• United States: The U.S. remains the largest market and leader in medtech innovation. The focus on advanced technologies and platform ecosystems reinforces its position. However, supply chain vulnerabilities necessitate strengthening domestic manufacturing and collaboration with Canada and Mexico.
• Canada: Canada's strengths in research and specialized manufacturing make it a key partner in R&D and high-value components. Its participation in USMCA and stable trade environment attract investment.
• Mexico: Mexico emerges as a manufacturing hub for medical devices, benefiting from cost advantages and trade preferences. The nearshoring trend is accelerating FDI, particularly in the border region, creating jobs and industrial capacity.
• USMCA: The agreement provides a framework for regulatory coherence and tariff-free trade within the region, facilitating integrated supply chains and enabling the expansion of cross-border manufacturing.

Future Outlook (3-5 Years)

Over the next half-decade, North America is likely to see deeper integration of medtech manufacturing driven by USMCA incentives and global supply chain realignment. Investment in cross-border infrastructure and digital logistics will be essential to support increased trade. AI and advanced manufacturing will enable greater flexibility and resilience, attracting further investment in the region. The medical technology sector could become a model for other industries seeking to balance efficiency with reliability. However, policy uncertainty and global competition, particularly from Asia, remain threats that require active regional cooperation.

Conclusion

The medtech trends to watch in 2026 signal a period of significant transformation. For North America, these trends underscore the importance of supply chain resilience, technological leadership, and regional cooperation. By leveraging the USMCA and investing in advanced manufacturing, the region can strengthen its position in the global medtech industry. Trade and industrial policy must evolve to support these shifts, ensuring that North America remains competitive in a rapidly changing global market.

Key Takeaways

• China's VBP is reshaping global pricing, pushing North American firms toward higher-value products.
• Outpatient migration expands demand for certain devices and challenges traditional commercial models.
• Supply chain pressures accelerate nearshoring to Mexico, increasing FDI and cross-border trade.
• GLP-1 adoption creates ripple effects, requiring strategic portfolio adjustments.
• Platform-based competition in medtech aligns with North American strengths in AI and advanced manufacturing.